Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Influenza

Free Subscription 23.03.2026 1 Cell 2 J Immunol 1 J Infect 5 J Infect Dis 1 J Virol 1 MMWR Morb Mortal Wkly Rep 1 PLoS Biol 2 PLoS Comput Biol 1 PLoS Med 22 PLoS One 3 Proc Natl Acad Sci U S A 37 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Cell

1. VARGAS-MALDONADO N, Shetty N, Ferreri LM, Pauly MD, et al
   Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.
   Cell. 2026 Mar 19:S0092-8674(26)00232-1. doi: 10.1016/j.cell.2026.
   PubMed         Abstract available
   
   

   
   J Immunol

2. VAHED H, Chentoufi AA, Prakash S, Quadiri A, et al
   CXCL13/CXCR5 chemokine axis promotes antiviral CXCR5+CD19+ B Cells and follicular/effector CXCR5+CD4+ T Cells in the lungs associated with protection from severe and fatal COVID-19 following infection with pathogenic SARS-CoV-2 Delta variant.
   J Immunol. 2026;215:vkag017.
   PubMed         Abstract available
   
   
3. HANSEN MR, Sedney CJ, Xiao S, Prasad DBR, et al
   Adult mice with neonatal-like T cell subsets exhibit increased susceptibility to Bordetella pertussis and influenza infection.
   J Immunol. 2026;215:vkaf361.
   PubMed         Abstract available
   
   

   
   J Infect

4. LOWA A, Budt M, Balazs A, Sikora V, et al
   Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract models.
   J Infect. 2026;92:106722.
   PubMed        
   
   

   
   J Infect Dis

5. RAYENS E, Sy LS, Qian L, Ackerson BK, et al
   Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus.
   J Infect Dis. 2026;233:e651-e661.
   PubMed         Abstract available
   
   
6. FOLLMANN D, Dang L, Chu E, Fintzi J, et al
   A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples.
   J Infect Dis. 2026;233:e646-e650.
   PubMed         Abstract available
   
   
7. KULLBERG RFJ, Appelman B, Galenkamp H, Prins M, et al
   Gut Microbiota Predicts the Risk of Future COVID-19 Hospitalization and Mortality: Insights From the Population-Based HELIUS Study.
   J Infect Dis. 2026;233:e823-e827.
   PubMed         Abstract available
   
   
8. LINHARES ABREU NETTO R, Chen C, Mwangi VI, Padron de Morais CE, et al
   Autoantibodies Against Type I Interferons are a Prominent Feature in SARS-CoV-2 Fatal Disease and Hospitalization.
   J Infect Dis. 2026;233:498-509.
   PubMed         Abstract available
   
   
9. SMITH C, Curtis K, Bonham A, Boyer S, et al
   Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory Syncytial Virus in HIV-Exposed Uninfected Infants.
   J Infect Dis. 2025 Sep 24:jiaf493. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

10. LIU B, Yu H, Yan Z, Zou S, et al
    Identification of thermostability-enhancing mutations in H9N2 avian influenza virus hemagglutinin.
    J Virol. 2026 Mar 16:e0016826. doi: 10.1128/jvi.00168.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

11. SHAKYA M, Ma KC, Hughes LJ, Smith C, et al
    Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 - Worldwide, November 2024-February 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:130-137.
    PubMed         Abstract available
    
    

    
    PLoS Biol

12. YUKSEL M, Mideo N
    Host jumps need not be common just because spillover is.
    PLoS Biol. 2026;24:e3003682.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

13. WANG X
    Bayesian-calibrated global sensitivity analysis for mathematical models using generative AI.
    PLoS Comput Biol. 2026;22:e1013312.
    PubMed         Abstract available
    
    
14. OKADA Y, Nishiura H
    Reconstructing the incidence rate and immune fraction of the population via a single snapshot survey: A case study of COVID-19 in Japan.
    PLoS Comput Biol. 2026;22:e1013990.
    PubMed         Abstract available
    
    

    
    PLoS Med

15. ABDEL-QADIR H, Bhatt HA, Swayze S, Paterson M, et al
    Association between COVID-19 vaccination and sudden death in apparently healthy younger individuals: A population-based case-control study.
    PLoS Med. 2026;23:e1004924.
    PubMed         Abstract available
    
    

    
    PLoS One

16. MUWONGE H, Namulondo J, Mugenyi L, Nakaseegu J, et al
    Respiratory syncytial virus burden among Ugandan adults aged >/=65 years: A 15-year sentinel surveillance study of prevalence, coinfections, and comorbidities (2010-2025).
    PLoS One. 2026;21:e0333329.
    PubMed         Abstract available
    
    
17. JEONG YM, Kim M, Jeong JY
    Behavior-biological mismatch in metabolic health: Evidence from South Korean adults before, during, and after COVID-19 (KNHANES 2019-2022).
    PLoS One. 2026;21:e0344918.
    PubMed         Abstract available
    
    
18. JACOBSEN V, Vazquez EA, Herrera L, Escalera R, et al
    Development of a survey and worry score to evaluate physician burnout and wellness interventions during COVID-19 in the Rio Grande Valley: A pilot study.
    PLoS One. 2026;21:e0342993.
    PubMed         Abstract available
    
    
19. JEONG YW
    Predictors of non-suicidal self-injury and moderating effects of cognitive emotion regulation strategies in Korean undergraduate students: Secondary data analysis of a cross-sectional survey.
    PLoS One. 2026;21:e0344175.
    PubMed         Abstract available
    
    
20. LEONARD RA, Truesdale M, Brown M, Marsh L, et al
    A randomised controlled feasibility study of the Carers-ID intervention to support the mental health of family carers of people with intellectual disabilities.
    PLoS One. 2026;21:e0345096.
    PubMed         Abstract available
    
    
21. REINER-BENAIM A, Amar S
    Factors associated with patient adherence to medical recommendations during a health crisis.
    PLoS One. 2026;21:e0345375.
    PubMed         Abstract available
    
    
22. WILHITE JA, Altshuler L, D'Angelo AB, Raykov A, et al
    "It makes me feel so much safer": Sexual and gender minority community perspectives on telehealth use and implications for future practice.
    PLoS One. 2026;21:e0345296.
    PubMed         Abstract available
    
    
23. SANKAR S, Anandharaman K, Selvam P, Jayaraman A, et al
    Genomic evolution of SARS-CoV-2 delta variants pre- and post-omicron emergence using alignment-free machine learning models.
    PLoS One. 2026;21:e0345259.
    PubMed         Abstract available
    
    
24. ESPERANCA M, Galvao T, Freitas D, Ferreira JC, et al
    Integrating medical imaging datasets with blockchain wallets: A case study on ARDS-COVID19 patients.
    PLoS One. 2026;21:e0338897.
    PubMed         Abstract available
    
    
25. PHAM ANQ, Smith J, Byers KA, Card KG, et al
    Associations between demographic, clinical, and socioeconomic factors and mental health in long COVID: A clinic-based cross-sectional study.
    PLoS One. 2026;21:e0342516.
    PubMed         Abstract available
    
    
26. SEKI M, Kobayashi Y, Meroc E, Kitano T, et al
    Estimation of Respiratory Syncytial Virus-attributable hospitalizations among older adults in Japan between 2015 and 2018: An administrative health claims database analysis.
    PLoS One. 2026;21:e0344294.
    PubMed         Abstract available
    
    
27. BROCK J, Lux H, Lang S, Winning J, et al
    Health care system resilience - Evaluating the effect of the COVID-19 pandemic on emergency medical service demand in Germany: A case study from the city of Jena.
    PLoS One. 2026;21:e0344992.
    PubMed         Abstract available
    
    
28. GODIA PM, Hadjiconstantinou M, Weyula R, Ememwa U, et al
    Development of a collaborative chronic care model for management of cardiometabolic disease in low- and middle-income countries.
    PLoS One. 2026;21:e0344527.
    PubMed         Abstract available
    
    
29. LASKE MM, Blackman AL, Oda FS, Reed DD, et al
    Risk identification strategies for health pandemics and epidemics on college campuses: A comprehensive analysis of heat maps and behavioral observations.
    PLoS One. 2026;21:e0343811.
    PubMed         Abstract available
    
    
30. HU A, Pang J, Gan X
    Decisions about risk taking: Elaborate dynamics between guests and hosts of peer-to-peer accommodation during COVID-19.
    PLoS One. 2026;21:e0341733.
    PubMed         Abstract available
    
    
31. GETTLER LT, Hoegler Dennis S, Rosenbaum S, Bechayda SA, et al
    Fathers' caregiving time before and after the COVID-19 pandemic.
    PLoS One. 2026;21:e0343636.
    PubMed         Abstract available
    
    
32. MUKENGE EK, Lengo CN, Sumbu BM, Muwonga JM, et al
    Serum levels of immunoglobulin G and M antibodies against SARS-CoV-2 in asymptomatic individuals prior to COVID-19 vaccination in the Democratic Republic of Congo.
    PLoS One. 2026;21:e0343362.
    PubMed         Abstract available
    
    
33. GASVAER KS, Lind PG, Langguth J, Hjorth-Jensen M, et al
    The 5G COVID-19 Digital Wildfire: An evolving network of Twitter contacts to explore phase transition metaphors in viral misinformation.
    PLoS One. 2026;21:e0343661.
    PubMed         Abstract available
    
    
34. ARIANI Y, Gunawan I, Susanto AD, Sutarto R, et al
    Early clinical and laboratory markers associated with post-COVID respiratory syndrome: A retrospective analysis.
    PLoS One. 2026;21:e0344371.
    PubMed         Abstract available
    
    
35. FILAMANT TC, Raherinirina AF, Totohasina A
    Bayesian networks for predicting clinical outcomes in COVID-19 patients: A retrospective study in a resource-limited setting.
    PLoS One. 2026;21:e0343096.
    PubMed         Abstract available
    
    
36. RASUL MG, Khan AR, Alam MA, Ahmed T, et al
    Understanding effectiveness of a low-cost food package for ensuring food security during the COVID-19 at the household level: Difference-in-differences analyses of a quasi-experimental trial in Bangladesh.
    PLoS One. 2026;21:e0344609.
    PubMed         Abstract available
    
    
37. HWANG J
    Navigating COVID-19: Association between public perceptions of preventive measures and delayed or foregone care among young and middle-aged Korean adults in the early phase of the pandemic.
    PLoS One. 2026;21:e0344209.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. TUNG W, Yuen M, Cai H, Cho H, et al
    Mild SARS-CoV-2 maternal infection in mice induces transient offspring neurodevelopmental aberrance.
    Proc Natl Acad Sci U S A. 2026;123:e2518294123.
    PubMed         Abstract available
    
    
39. MOHLENBERG M, Jorgensen SE, Marije van der Sluis R, Zillinger T, et al
    Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2026;123:e2522111123.
    PubMed         Abstract available
    
    
40. LAU MSY, Metcalf CJE, Liu Z, Grenfell BT, et al
    Toward AI foundation models for epidemics: Promise, challenges, and paths forward.
    Proc Natl Acad Sci U S A. 2026;123:e2526192123.
    PubMed         Abstract available
    
    

    
    Vaccine

41. ANWER K, Musso L, Lasrado N, Barouch DH, et al
    Safe and durable immune responses to a single dose DNA COVID-19 vaccine in previously vaccinated or SARS-CoV-2-infected adults: A phase 1 study.
    Vaccine. 2026;77:128357.
    PubMed         Abstract available
    
    
42. TAL-SINGER R, McCreary G, Luttmann M, Williams S, et al
    Attitudes toward vaccines and antivirals for viral respiratory infections in a survey of US adults with chronic health conditions.
    Vaccine. 2026;77:128384.
    PubMed         Abstract available
    
    
43. DERAZ N, Payne M, See E, Ragavapuram V, et al
    XBB 1.5 monovalent booster vaccination stimulates oral mucosal and systemic immune responses in healthy adults.
    Vaccine. 2026;77:128346.
    PubMed         Abstract available
    
    
44. LI R, Vafeiadis M, Shen F, Hou Z, et al
    The role of health beliefs in COVID-19 vaccination acceptance: A Meta-analysis.
    Vaccine. 2026;77:128379.
    PubMed         Abstract available
    
    
45. HUDSON A, Borgetti S, Rick AM, Laurens MB, et al
    Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.
    Vaccine. 2026;77:128380.
    PubMed         Abstract available
    
    
46. SOHN WY, Goody SMG, Reid DW, Edwards DK, et al
    Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines.
    Vaccine. 2026;77:128394.
    PubMed         Abstract available
    
    
47. EKSTROM N, Liedes O, Vara S, Haveri A, et al
    Immune responses following sequential mRNA booster doses targeting the SARS-CoV-2 omicron variants in immunocompromised individuals - A 3.5-year follow-up.
    Vaccine. 2026;77:128347.
    PubMed         Abstract available
    
    
48. BOETTIGER DC, Carlson SJ, Adams SR, Tse V, et al
    Unequal access: Respiratory syncytial virus vaccine uptake by socioeconomic status among older adults in Australia.
    Vaccine. 2026;77:128395.
    PubMed         Abstract available
    
    
49. WHITAKER JA, Rebolledo PA, Abate G, Babu TM, et al
    The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.
    Vaccine. 2026;77:128358.
    PubMed         Abstract available
    
    
50. SANO K, Kato H, Ryo A, Hasegawa H, et al
    Immune response and IgG subclass dynamics following repeated SARS-CoV-2 mRNA vaccination in Japanese healthcare workers.
    Vaccine. 2026;77:128396.
    PubMed         Abstract available
    
    
51. DAVIS M, Shapiro C, Ciarlet M, Adams EM, et al
    A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-85 years of age.
    Vaccine. 2026;77:128345.
    PubMed         Abstract available
    
    
52. NUZHATH T, Yang Y, Couture MC, Callaghan T, et al
    Modification and validation of the teen vaccine hesitancy scale toward vaccines for adolescents.
    Vaccine. 2026;77:128385.
    PubMed         Abstract available
    
    
53. GOODFELLOW L, Soble A, Malvolti S, Lambach P, et al
    The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling study.
    Vaccine. 2026;60 Suppl 2:128455.
    PubMed         Abstract available
    
    
54. YE Q, Chen H, Jia B, Chen X, et al
    Uptake and effectiveness of a novel seasonal influenza vaccination campaign for school-age children in the 2023/2024 influenza season in Shanghai, China.
    Vaccine. 2026;79:128478.
    PubMed         Abstract available
    
    
55. HUNG HC, Jheng KW, Cheng HY, Hsieh HC, et al
    Intranasal prime-boost immunization with trivalent influenza virus neuraminidase proteins and conserved HCA2 sequences fused to a circularly permuted E. coli heat-labile enterotoxin B subunit.
    Vaccine. 2026;79:128488.
    PubMed         Abstract available
    
    
56. DE LOOZE F, Essink BJ, van Boxmeer J, Andrade C, et al
    Immunogenicity and safety of higher-dose cell-based adjuvanted quadrivalent influenza vaccines: Combined results of randomised, controlled dose-finding and dose-confirmation studies.
    Vaccine. 2026;79:128436.
    PubMed         Abstract available
    
    
57. DEMIRDEN SF, Kimiz-Gebologlu I, Oncel SS
    Comparative evaluation of cell lines and their serum-free adapted derivatives for H1N1 influenza A virus propagation: bridging laboratory research and industrial vaccine production application.
    Vaccine. 2026;79:128489.
    PubMed         Abstract available
    
    
58. HENG F, Magaret CA, Rouphael NG, Branche AR, et al
    The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.
    Vaccine. 2026;76:128348.
    PubMed         Abstract available
    
    
59. FRANCK Z, Hofstraat S, Jonker L, Kragten L, et al
    The evolving landscape of RSV immunization: Current policies and practices across Europe.
    Vaccine. 2026;76:128222.
    PubMed         Abstract available
    
    
60. IMANISHI Y, Iorini M, Wada I, Jwa S, et al
    Child sexual abuse and adult vaccination: Opposing patterns between routine and pandemic vaccines in a Nationwide survey.
    Vaccine. 2026;76:128299.
    PubMed         Abstract available
    
    
61. PARIS L, Domegan L, O'Leary M, Hanrahan M, et al
    Protecting infants from respiratory syncytial virus (RSV) in Ireland: Impact of a national nirsevimab immunisation programme, 2024/2025.
    Vaccine. 2026;76:128344.
    PubMed         Abstract available
    
    
62. MAKI W, Ishitsuka K, Morisaki N, Machida M, et al
    Association of parental vaccination readiness and descriptive norms with childhood vaccination status.
    Vaccine. 2026;76:128337.
    PubMed         Abstract available
    
    
63. OGAWA T, Sunyi J, Kawachi K, Murakami J, et al
    Regulatory approaches for platform-based vaccine development in Japan: Insights from PMDA's experience with COVID-19 and RSV vaccines.
    Vaccine. 2026;76:128315.
    PubMed         Abstract available
    
    
64. STEFKOVICS A, Ligeti AS, Koltai J
    Willingness to vaccinate in a future pandemic. Evidence from a vignette experiment.
    Vaccine. 2026;76:128284.
    PubMed         Abstract available
    
    
65. URIU K, Kaku Y, Kosugi Y, Chen L, et al
    Humoral immunity induced by XEC monovalent vaccines against SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2.
    Vaccine. 2026;76:128311.
    PubMed         Abstract available
    
    
66. CAO Q, Du S, Yang K, Liu M, et al
    Assessing the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive techniques outcomes: an umbrella review.
    Vaccine. 2026;76:128293.
    PubMed         Abstract available
    
    
67. GREWAL R, Alessandrini J, Wilson SE, Hernandez A, et al
    Human papillomavirus (HPV) vaccine coverage and associated sociodemographic factors among individuals eligible for publicly funded vaccine in Ontario, Canada from 2007 to 2023: A Canadian immunization research network study.
    Vaccine. 2026;76:128303.
    PubMed         Abstract available
    
    
68. OYEDELE T, Park R, Morales K, Jain M, et al
    A novel SARS-CoV-2 mRNA virus-like particle vaccine is highly potent and well tolerated in adults in a phase 1 randomized clinical trial.
    Vaccine. 2026;76:128304.
    PubMed         Abstract available
    
    
69. STEFFENS M, Bolsewicz K, Prokopovich K, Beard F, et al
    Immunisation program managers' experiences of implementing the change from a two dose to a single dose course of HPV vaccination in Australia's school-based program.
    Vaccine. 2026;76:128300.
    PubMed         Abstract available
    
    
70. SMITH EA, Malhame M, Malvolti S, Voss G, et al
    Use cases for pan-sarbecovirus vaccines: a workshop report.
    Vaccine. 2026;76:128312.
    PubMed         Abstract available
    
    
71. ALMEIDA ST, Paulo AC, Simoes AS, Handem S, et al
    Pneumococcal carriage and serotype distribution in Portuguese children six months after the lifting of COVID-19 restrictions: rise in serotype 3 amid stable non-vaccine serotypes.
    Vaccine. 2026;76:128294.
    PubMed         Abstract available
    
    
72. MELAKU T, Gudina EK, Sorensen JB, Draebel TA, et al
    Trends and recovery of routine childhood immunization before, during, and after the COVID-19 pandemic in Ethiopia: A five-year trend analysis.
    Vaccine. 2026;77:128343.
    PubMed         Abstract available
    
    
73. MADLEY-DOWD P, Horne EMF, Hulme WJ, Palmer TM, et al
    Effectiveness of bivalent BA.1 mRNA booster vaccines during the autumn 2022 COVID-19 booster programme in adults aged 50+ in England: observational matched cohort study using OpenSAFELY.
    Vaccine. 2026 Feb 18:128276. doi: 10.1016/j.vaccine.2026.128276.
    PubMed         Abstract available
    
    
74. MADNI SA, Olson CK, Zauche LH, Machefsky A, et al
    Risk of spontaneous abortion after mRNA COVID-19 vaccination received just prior to or during pregnancy: Complete data from CDC COVID-19 vaccine pregnancy registry.
    Vaccine. 2026;76:128340.
    PubMed         Abstract available
    
    
75. BARBOZA APB, Luna-Muschi A, Faffe D, Borges IC, et al
    Protective effect of a second booster dose against long COVID among individuals infected with SARS-CoV-2 in southeastern Brazil.
    Vaccine. 2026;77:128354.
    PubMed         Abstract available
    
    
76. CHANDRA LA, Nugroho DB, Thobari JA, Dimaguila GL, et al
    Active surveillance methods to identify adverse events of special interest (AESIs) following vaccination against pandemic diseases: A scoping review.
    Vaccine. 2026;77:128341.
    PubMed         Abstract available
    
    
77. MORENO MZ, Martin JJP
    Evaluation of the impact of different notification methods for unvaccinated individuals in a ACWY meningococcal vaccination campaign.
    Vaccine. 2026;77:128383.
    PubMed         Abstract available
    
    

    
    Virus Res

78. XIE C, Zhao Y, Wang B, He T, et al
    Identification of key genes modules linking brain aging signatures and COVID-19-associated cognitive impairment.
    Virus Res. 2026;366:199707.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum